Clinical Journal of the American Society of Nephrology · 2013 · 55 citations · 43 references
MedicineNephrologySurgeryDialysisHemodialysisRenal Replacement TherapyDialysis AccessDialysis Access InterventionsDialysis Vascular AccessEnd-stage Kidney Disease CareVascular AccessVascular Access CareAccess Mode ChoiceArteriovenous Graft PlacementCkd ProgressionDialysis IndicationsPatient ContextTunneled Venous CathetersTunnelled Central Venous CathetersVascular Access Patency
The main options for vascular access in hemodialysis patients are arteriovenous fistulas (AVFs), arteriovenous grafts, and tunneled cuffed central venous catheters. AVFs have the lowest complication rate and require the fewest interventions and lowest cost to maintain. There has been a dramatic national increase in prevalent AVFs among patients with ESRD in the United States driven, in part, by the Fistula First Breakthrough Initiative. The Fistula First Breakthrough Initiative has engaged stakeholders in the dialysis community to disseminate best practices and quality improvement activities to increase AVF prevalence in suitable candidates. In the pursuit of maximizing AVF placement and prevalence, less emphasis has been placed on the individual patient context. An AVF may not be the best access choice in a subset of patients, particularly those with poor long-term prognoses or comorbid chronic diseases with a short life expectancy, those patients more likely to die than to have their CKD progress to ESRD requiring dialysis, and those with vascular anatomy not amenable to successful AVF placement. Placement of an AVF in these patients subjects them to uncomfortable and likely unnecessary and/or unsuccessful surgeries at an expense, while doing little to improve their clinical outcome or their individual experience of care. AVF prevalence as a pay-for-performance measure without the appropriate case-mix adjustment may penalize providers for accepting higher-risk patients. Although a functioning AVF that provides reliable hemodialysis remains the gold standard for vascular access for most patients, it may not be the most suitable option for every patient.
43
The clinical evaluation of chemotherapeutic agents in cancer
David A. Karnofsky · Medical Entomology and Zoology · 1949 · 2.9K citations
Medicine, Oncology, Pharmacology +14
Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for Hemodialysis
Laura M. Dember, Gerald J. Beck, Michael Allon et al. · JAMA · 2008 · 817 citations · Full text
Age Affects Outcomes in Chronic Kidney Disease
Ann M. O’Hare, Andy I. Choi, Daniel Bertenthal et al. · Journal of the American Society of Nephrology · 2007 · 745 citations
Jan Tordoir, Bernard Canaud, Patrick Haage et al. · Nephrology Dialysis Transplantation · 2007 · 641 citations · Full text